Drug intelligence / Profile preview

68Ga-triacetylfusarinine C

Development stage
Unknown
Lead developer
Medical University of Innsbruck
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Small Molecules, Peptides
Administration
Intravenous
01

Overview

68Ga-triacetylfusarinine C (68Ga-TAFC) is an investigational radiopharmaceutical diagnostic PET imaging tracer designed for the detection of invasive aspergillosis, a severe fungal infection caused by *Aspergillus fumigatus*. The tracer consists of the natural fungal siderophore triacetylfusarinine C (TAFC) labeled with the positron-emitting radionuclide gallium-68 (68Ga). TAFC is an iron chelator secreted by *A. fumigatus* to scavenge iron from the host. Once chelated with iron (or its chemical mimic, gallium-68), the complex is actively internalized by the fungus via the highly upregulated major facilitator-type transporter MirB. This pathogen-specific uptake mechanism allows for highly selective PET/CT imaging of active fungal infections, with rapid renal clearance and minimal background uptake in sterile inflammation or bacterial abscesses. It is being evaluated in clinical trials, such as the 'SPECIFIC' pilot study, for the non-invasive diagnosis of invasive pulmonary aspergillosis.

Other names
68Ga-TAFC[68Ga]TAFCgallium-68 triacetylfusarinine Cgallium68 triacetylfusarinine Cgallium 68 triacetylfusarinine Ctriacetylfusarinine C labelled with gallium-68
02

Targets

MirB (MFS siderochrome iron transporter B)

Beyond the preview

Go deeper on 68Ga-triacetylfusarinine C.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 68Ga-triacetylfusarinine C.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call